文献速递传染病防控与疫情报告免疫规划

2024年上海儿童医院百日咳流行病学与临床特征及耐药分析

[Epidemiological and clinical characteristics of pertussis in children at a tertiary pediatric hospital in Shanghai City in 2024].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2026-01-01

住院病例痉挛性咳嗽、青紫、呼吸暂停等发生率及并发症、混合感染比例均高于门诊(均P<0.001);2月龄以下未接种疫苗婴儿重症风险高,166株分离株中165株(99.4%)对阿奇霉素高水平耐药。

要点

  • 4~10岁儿童是2024年上海百日咳主要发病人群,占78.2%。
  • 2月龄以下未接种疫苗婴儿重症高危,住院率64.8%。
  • 166株分离株中99.4%对阿奇霉素高水平耐药,不推荐经验使用大环内酯类。

核心结论

  • 4~10岁儿童是2024年上海地区百日咳暴发时期的主要发病人群。
  • 2月龄以下未接种疫苗婴儿是重症病例高危人群。
  • 不推荐经验使用大环内酯类药物治疗百日咳。

研究设计与样本

  • 收集2024年复旦大学附属儿科医院核酸检测确诊百日咳患者的人口学信息和疫苗接种信息。
  • 采集部分患者鼻咽拭子进行百日咳鲍特菌培养和药物敏感性检测,共166株分离株。

主要发现

  • 住院患者痉挛性咳嗽、鸡鸣样尾声、青紫发作、呼吸暂停、发热、外周血白细胞计数≥20×10⁹/L发生率分别为94.8%、35.0%、24.2%、21.6%、44.8%、26.1%,均高于门诊患者的75.0%、14.6%、1.7%、1.3%、23.5%、4.0%(均P<0.001)。
  • 住院患者合并并发症、混合感染比例分别为64.1%、70.6%,均高于门诊患者的19.3%、13.8%(均P<0.001)。
  • 0~2月龄婴幼儿住院率64.8%(83/128);14例(4.6%)为重症,其中2例死亡,12例未接种疫苗,其中9例为0~2月龄婴儿。

关键数值与推荐

  • 166株百日咳鲍特菌分离株中,165株(99.4%)对阿奇霉素高水平耐药(MIC>256.000 μg/ml)。
  • 分离株对甲氧苄啶-磺胺甲恶唑、左氧氟沙星、头孢他啶、头孢哌酮/舒巴坦、多西环素体外敏感。

临床怎么用

  • 4~10岁儿童出现阵发性咳嗽等表现时应考虑百日咳,尤其在4~7月流行高峰。
  • 2月龄以下未接种疫苗婴儿出现鸡鸣样尾声、青紫、呼吸暂停等应警惕重症,及时住院评估。
  • 治疗百日咳不推荐经验使用大环内酯类,需依据药敏结果选择敏感药物。
  • 住院患者并发症和混合感染比例高,应加强监测与综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the epidemiological and clinical characteristics of pertussis in children diagnosed at the Affiliated Children's Hospital of Fudan University in Shanghai in 2024, as well as the antimicrobial resistance patterns of Bordetella pertussis. Methods: Demographic information and vaccination status were collected from the pertussis cases confirmed by nucleic acid testing at the Children's Hospital of Fudan University in 2024. Clinical data from all hospitalized pertussis cases and a portion of outpatient pertussis cases were collected to analyze their clinical characteristics. Bordetella pertussis was isolated from nasopharyngeal swab specimens of some cases, and antimicrobial susceptibility was tested. Results: Among the 9 899 cases diagnosed in 2024, 5 272 were males and 4 627 were females. The peak epidemic season occurred from April to July. Children aged 4-10 years accounted for 7 744 cases (78.2%). Among 6 947 cases with available vaccination records, 6 676 (96.1%) had completed the full course of pertussis vaccination. A total of 2 085 pertussis patients were included for analysis of clinical characteristics, including 1 779 outpatient cases and all 306 hospitalized cases. The incidence rates of paroxysmal cough, whoop, cyanosis, apnea, fever, and white blood cell counts ≥20×10⁹/L in hospitalized patients were 94.8%, 35.0%, 24.2%, 21.6%, 44.8%, and 26.1%, respectively, all significantly higher than those in outpatient cases (75.0%, 14.6%, 1.7%, 1.3%, 23.5%, and 4.0%; all P<0.001). The proportions of complications and co-infections in hospitalized patients were 64.1% and 70.6%, respectively, also significantly higher than those in outpatient cases (19.3% and 13.8%; both P<0.001). Among both outpatient and hospitalized patients, infants under 7 months were more prone to whoop, cyanosis, apnea, post-tussive vomiting, and peripheral white blood cell counts≥20×10⁹/L compared to those older than 7 months, with statistical significance (all P<0.001). The hospitalization rates were highest among infants aged 0~2 months at 64.8% (83/128). The median length of hospital stay [M (Q1, Q3)] was 3.5 (2.5, 5.5) days, and the median hospitalization cost [M (Q1, Q3)] was RMB 8 351.6 (6 934.6, 12 086.4) among hospitalized cases. There were 14 severe cases (4.6 %), including 2 deaths. Twelve severe cases were unvaccinated, of which 9 were infants aged 0~2 months. The average length of hospital stay for severe cases was (30.7±17.7) days, with a median average cost [M (Q1, Q3)] of RMB 107 996.2 (42 066.9, 133 530.9). Based on minimum inhibitory concentration (MIC) testing of 166 Bordetella pertussis isolates, 165 (99.4%) exhibited high-level resistance to azithromycin (MIC>256.000 μg/ml). The isolates remained susceptible in vitro to trimethoprim-sulfamethoxazole, levofloxacin, ceftazidime, cefoperazone-sulbactam, and doxycycline. Conclusion: Children aged 4-10 years are the primary affected group during the 2024 pertussis outbreak in Shanghai. Unvaccinated infants under 2 months of age are at high risk for severe disease. Empirical use of macrolides for pertussis treatment is not recommended. 目的: 分析2024年上海市复旦大学附属儿科医院诊断的儿童百日咳的流行病学和临床特征,以及百日咳鲍特菌的耐药模式。 方法: 收集2024年复旦大学附属儿科医院核酸检测确诊的百日咳患者的人口学信息和疫苗接种信息;同时收集2024年全部住院和部分门诊确诊百日咳患者的临床资料,分析其临床特点。采集部分患者的鼻咽拭子标本进行百日咳鲍特菌培养和药物敏感性检测。 结果: 2024年共确诊9 899 例百日咳患者,其中男5 272例,女4 627例;4~7月为流行高峰季节;78.2%的患者为4~10岁儿童(7 744例);有疫苗接种信息的6 947例患者中,6 676例(96.1%)完成全程百日咳疫苗接种。共2 085例百日咳患者分析其临床特点,包括1 779例门诊和306 例住院患者。其中住院患者痉挛性咳嗽、鸡鸣样尾声、青紫发作、呼吸暂停、发热、外周血白细胞计数≥20×109/L的发生率分别为94.8%、35.0%、24.2%、21.6%、44.8%、26.1%,均高于门诊患者的75.0%、14.6%、1.7%、1.3%、23.5%、4.0%(均P<0.001);住院患者合并并发症、混合感染的比例分别为64.1%、70.6%,均高于门诊患者的19.3%、13.8%(均P<0.001)。门诊和住院患者中,7月龄以下婴幼儿较7月龄以上均更易发生鸡鸣样尾声、青紫发作、呼吸暂停、咳嗽后呕吐、外周血白细胞计数≥20×109/L,统计学有差异(均P<0.001)。0~2月龄婴幼儿住院率较高为64.8%(83/128);住院患者住院天数M(Q1,Q3)为3.5(2.5,5.5)d,住院医疗费用M(Q1,Q3)为8 351.6(6 934.6,12 086.4)元。14例(4.6%)为重症,其中2例死亡;12例未接种疫苗,其中9例为0~2月龄婴儿;重症患者平均住院日为(30.7±17.7)d,住院医疗费用M(Q1,Q3)为107 996.2(42 066.9,133 530.9)元。166株百日咳鲍特菌分离株的最低抑菌浓度检测,165株(99.4%)对阿奇霉素高水平耐药(MIC>256.000 μg/ml),对甲氧苄啶-磺胺甲恶唑、左氧氟沙星、头孢他啶、头孢哌酮/舒巴坦、多西环素体外敏感。 结论: 4~10岁儿童是2024年上海地区百日咳暴发时期的主要发病人群,2月龄以下未接种疫苗婴儿是重症病例高危人群。不推荐经验使用大环内酯类药物治疗百日咳。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu QY, Zeng M, Chang HL, et al. [Epidemiological and clinical characteristics of pertussis in children at a tertiary pediatric hospital in Shanghai City in 2024]. Zhonghua Yu Fang Yi Xue Za Zhi. 2026. PMID: 42331531. doi:10.3760/cma.j.cn112150-20250709-00640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。